Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q3 2017: Growth and earnings impacted by a major customer’s destocking

Highlights and significant events in the third quarter · Continued destocking by major customer, impacting net sales and earnings during the second half of 2017 and first quarter of 2018 · New FerroSorb® and Digestis® FastMelt product launches in Asia and Europe · Extension of Ipsen distribution partnership to Italy · First results of multi-trial programme to develop a new probiotic platform for children show positive and significant results in supporting the immune system and in delaying the onset of gluten intolerance Financial overview MSEK

MetaboGen AB receives 4.9 MSEK for development of pharmaceutical products based on the microbiome

MetaboGen AB – a Swedish microbiome company – has been granted 4.9 MSEK by Sweden´s Innovation Agency, VINNOVA, for development of production- and formulation technologies for pharmaceutical products, based on bacterial strains isolated from the human gut.The human intestinal tract is inhabited by 10-100 trillion of microbes comprised of thousands of different species, collectively called the microbiota. This microbial community has an immense capacity to affect host biology and imbalance in the gut microbiome is today associated with multiple diseases and unhealthy conditions. The

Lagercrantz Interim Report 2017/18 Q2

Second quarter  1 July  –  30 September 2017 · Net revenue increased by 13 percent to MSEK 775 (684).   · Operating profit (EBITA) increased by 4 percent to MSEK 98 (94), equivalent to an operating margin of 12.6 percent (13.7). · Profit before financial items amounted to MSEK 83 (82), equivalent to an EBIT margin of 10.7 percent (12.0).   · Profit after financial items amounted to MSEK 78 (81) and profit after taxes amounted to MSEK 62 (63).   · Earnings per share after dilution for the latest 12-month period amounted to SEK 4.04 (3.72). · Return on equity was 23

Interim Report Rejlers AB January–September 2017

Continued transitionThird quarter• Sales increased by 8.9% to SEK 544.9 million (500.3)• Organic sales growth excluding exchange rate fluctuations amounted to -5.0 %• EBITA (adjusted) amounted to SEK 3.5 million (7.9) and the adjusted EBITA margin amounted to 0.6 % (1.6)• Operating profit amounted to SEK 0.5 million (4.9) and the operating margin was 0.1 % (1.0)• Profit/loss after tax was a loss of SEK 5.7 million (profit: 1.1)• Earnings per share before and after dilution were SEK -0.37 (0.12)• Cash flow from operating activities totalled SEK -35.0 million (-24.4) January-

Sobi™ publishes its report for the third quarter 2017

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the third quarter 2017. Total revenues amounted to SEK 1,601 M, an increase of 37 per cent. Product sales amounted to SEK 1,459 M, an increase of 45 per cent. Elocta® sales were SEK 417 M and Alprolix® sales were SEK 98 M. Business highlights Q3 2017 · Focus on future growth · 37 per cent sales growth in the quarter · 601 per cent product sales growth in Haemophilia · Solid development for Orfadin® 20 mg and oral suspension in the US Financial summary Q3 2017 (Q3 2016) ·

Finnish Raiha Hydraulics opens a representative office in Russia

Finnish company Raiha Hydraulics  opens its first office in St. Petersburg. The Russian office consists of former employees of GS-Hydro, a company that produced non-welded piping systems. Being a part of Hollming Group , Raiha Hydraulics designs new hydraulic systems, maintains and supplies equipment for the maritime, metal, pulp and paper, chemical, and oil industries, and works with all types of hydraulic motors, pumps, and cylinders. "Working with Raiha and Hollming gives us credibility among Russian clients and allows us

LeoVegas AB: Third quarter: 1 July-30 September 2017

"Acquisition of Royal Panda and a third quarter with continued strong organic growth and profitability"Gustaf Hagman, Group CEO and co-founder Third quarter: 1 July-30 September 2017[1] · Revenue increased by 40% to EUR 55.6 m (39.7). Organic growth was 33%. · Revenue from regulated markets accounted for 25.3% (13.2%) of total revenue. · Mobile deposits were 70% (67%) of total deposits, which increased by 56% to EUR 193.1 m (123.7). · The number of depositing customers was 202,980 (156,389), an increase of 30%. The number of new depositing customers was 97,210 (74,638),

DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-SEPTEMBER 2017

Detection Technology Plc Company Announcement 25 October 2017 at 9:00 (EEST) DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-SEPTEMBER 2017 Detection Technology Q3: Medical applications driving strong growth July-September 2017 highlights · Net sales increased by 16.1% to EUR 22.2 million (19.2) · Net sales of Security and Industrial Business Unit (SBU) decreased by 5.2% to EUR 13.3 million (14.1) · Net sales of Medical Business Unit (MBU) increased by 74.8% to EUR 8.9 million (5.1) · Operating profit (EBIT) was EUR 5.1 million (4.1) · Operating margin (EBIT-%)

Konecranes Plc Interim Report January-September 2017

KONECRANES PLC INTERIM REPORT OCTOBER 25, 2017 at 09.00 EET PROFITABILITY IMPROVEMENT CONTINUED, PORT SOLUTIONS ORDER INTAKE STRONG SALES GUIDANCE SLIGHTLY REDUCED This release is a summary of Konecranes Plc’s Interim Report January-September 2017. The complete report is attached to this release in pdf format and is also available on Konecranes’ website at www.konecranes.com. Figures in brackets, unless otherwise stated, refer to the same period a year earlier. THIRD QUARTER HIGHLIGHTS (COMPARISON TO COMBINED COMPANY FIGURES*) - Order intake EUR 750.1 million (685.3), +9.4

Redeye: Isofol Medical - Knowledge is Power

Today we initiate coverage of biotech company Isofol Medical, that developing Modufolin, a new therapy used in the treatment of colorectal cancer and as a rescue therapy after high-dose chemotherapy treatment. Continue reading at: https://goo.gl/YgXjvT Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se

SSAB aims to be fossil-free by 2045

SSAB increases the company ambitions for sustainability and sets new long-term objectives. By 2045 SSAB aims to be totally fossil-free. However, in the mid-term, the most noticeable sustainability impacts will be achieved by our sustainable offering: 10 million tonnes in annual customer CO2 savings by 2025. “In many respects we are already a forerunner and we want to retain that position in the future. The sustainability trend is transforming the steel industry and noticeable measures are required to mitigate climate change. Our new objectives are highly ambitious, but we feel

Interim report January-September 2017: Efficient development model with significant benefits for society

In its interim report for the third quarter of 2017, Victoria Park reports a high level of activity, which is generating significant value growth. · High renovation rate and continued strong market climate. · Attractive residential areas through densification projects. · Continued significant value growth. · Possession of 570 flats in Örebro and Gothenburg. JANUARY-SEPTEMBER 2017 · Revenues increased by 33 percent, to SEK 786 M (589). · Profit from property management increased by 50 percent to SEK 256 M (171), equal to SEK 1.06 per share (0.75). · Profit after

INTERIM REPORT NORDAX GROUP AB JANUARY-SEPTEMBER 2017

JANUARY-SEPTEMBER 2017 Numbers compared to January-September 2016 • The loan portfolio grew by 7%, in constant currencies by 9% • The net interest margin decreased to 9.1% (9.2%) • Total operating income increased to 892 MSEK (882). Adjusted total operating income increased to 901 MSEK (812) • Adjusted cost to income ratio (rolling 12 months) improved to 26.1% (27.7%) • Operating profit decreased to 403 MSEK (433). Adjusted operating profit increased by 17% to 421 MSEK (360) • Net profit decreased to 311 MSEK (336) • Earnings per share were 2.81 SEK (3.03). Adjusted

Ahlstrom-Munksjö interim report January-September 2017: Strong organic sales growth

AHLSTROM-MUNKSJÖ INTERIM REPORT RELEASE, OCTOBER 25, 2017 at 07:30 CEST This release is a summary of Ahlstrom-Munksjö’s’ interim financial report January-September 2017. The complete report is attached to this release as a pdf-file. It is also available at www.ahlstrom-munksjo.com. In this interim report, the January-September 2017 figures as well as all comparison figures are presented on a pro forma basis to illustrate the financial impact of the merger between Ahlstrom and Munksjö as if it had been completed at the beginning of 2015. Only the July-September 2017 and April-June 2017

Oriola Corporation’s Interim Report January-September 2017

Oriola Corporation Stock Exchange Release 25 October 2017 at 8.30 a.m. Oriola Corporation’s Interim Report January-September 2017 Financial performance July–September 2017, continuing operations · Invoicing increased by 1.3 (increased 4.7) per cent to EUR 823.1 (812.2) million · Net sales decreased by 1.4 (increased 4.7) per cent to EUR 377.6 (382.9) million · Adjusted EBITDA decreased by 27.3 (increased 1.8) per cent to EUR 16.7 (23.0) million · Adjusted EBIT was EUR 9.7 (16.5) million · Profit for the period totalled EUR 8.0 (11.8) million and earnings per share

Alfa Laval AB (publ) Interim report July 1 - September 30, 2017

“The order intake in the third quarter increased by 15 percent compared to the same quarter last year. The development was particularly strong in the Marine Division, primarily driven by a good order intake for environmental applications and an improved contracting for tankers at the ship yards. Geographically, the most positive development was seen in Asia and North America. Compared to the previous quarter, the order intake decreased as expected, mainly due to fewer bookings of large orders, fewer projects within Food & Water and a normal seasonality for HVAC applications. The adjusted

Storebrand ASA, 3rd Quarter 2017

· Group result of NOK 773m in the 3rd quarter 2017, NOK 2 322m year to date · Good topline growth within Savings and strong financial result · Solvency margin of 160% · Storebrand acquires Silver insurance portfolios and buys asset manager SKAGEN -          The strong operating result in the quarter is characterized by good volume growth within Savings combined with a good result in Insurance. Storebrand is succeeding in transferring it's business from guaranteed to non-guaranteed products, and at the same time managing to adapt costs to the new cost base, says CEO Odd Arild

Storebrand ASA acquires SKAGEN AS

Storebrand acquires SKAGEN and strengthens its position in a growing savings market - Storebrand is Norway's largest private asset manager and leading supplier of occupational pensions. SKAGEN has a strong position in the Norwegian savings market, with a clear investment philosophy and a strong brand. Together we want to provide our clients with even better savings options. We believe this is an offensive step towards increased growth in savings and pensions, which will increasingly become one market in the future,” says CEO of Storebrand Odd Arild Grefstad. A leading position in the

SpareBank 1 SR-Bank ASA (SRBANK); A very good result characterised by strong underlying operations

SpareBank 1 SR-Bank is posting a pre-tax profit of NOK 1,910 million for the year-to-date at the end of the third quarter of 2017, compared with NOK 1,633 million for the same period last year. The result is characterised by a significant increase in ordinary operating income and a moderate increase in the group's operating costs. The return on equity after tax was 10.9%, compared with 10.2% for the same period in 2016. The pre-tax profit for the quarter seen in isolation was NOK 750 million, compared with NOK 660 million for the same period last year, which is equivalent to a return

Report for the third quarter 2017: Positive trend in earnings and strong cash flow

The quarter · Sales were SEK 16,188 (13,477) million · Operating profit before depreciation/amortization was SEK 2,016 (1,635) million · Operating profit was SEK 1,089 (707) million · The result after financial items was SEK 864 (461) million · Earnings per share were SEK 0.56 (0.57) · Operating cash flow was SEK 1,590 (926) million · Net debt/equity ratio was 27% (35%)Comments by the CEO SSAB’s operating profit for the third quarter increased to SEK 1,089 (707) million. Higher prices and volumes drove the improvement compared to the same period 2016. Earnings were

Tokmanni Group:Third quarter revenue grew 4.5%, Like-for-Like growth 0.8%

TOKMANNI GROUP THIRD QUARTER: REVENUE GREW 4.5%, LIKE-FOR-LIKE GROWTH 0.8%   Numbers in brackets refer to the corresponding period previous year if nothing else is mentioned. THIRD QUARTER HIGHLIGHTS · Revenue grew 4.5% to EUR 195.4 million (187.0) · Like-for-Like revenue grew 0.8%, clearly above the market · 1 new store opened during the quarter · Comparable gross profit totaled EUR 66.0 million (64.8), 33.8% of revenue (34.7%) · Comparable EBITDA totaled EUR 16.2 million (18.1), 8.3% of revenue (9.7%) · Comparable EBIT totaled EUR 12.7 million (14.4), 6.5% of

Tokmanni Group:Third quarter revenue grew 4.5%, Like-for-Like growth 0.8%

TOKMANNI GROUP THIRD QUARTER: REVENUE GREW 4.5%, LIKE-FOR-LIKE GROWTH 0.8%   Numbers in brackets refer to the corresponding period previous year if nothing else is mentioned. THIRD QUARTER HIGHLIGHTS · Revenue grew 4.5% to EUR 195.4 million (187.0) · Like-for-Like revenue grew 0.8%, clearly above the market · 1 new store opened during the quarter · Comparable gross profit totaled EUR 66.0 million (64.8), 33.8% of revenue (34.7%) · Comparable EBITDA totaled EUR 16.2 million (18.1), 8.3% of revenue (9.7%) · Comparable EBIT totaled EUR 12.7 million (14.4), 6.5% of

Haldex interim report, January - September 2017: Revenue growth in an improved market

Sales in all of Haldex’s geographic regions increased in Q3, with Asia leading the way. The market has continued to develop positively, with the largest improvement in North America. Haldex strengthened its position in Europe during the quarter, but has not been able to grow to the same extent as in the North American market. A number of product areas have shown strong growth, including disc brakes. Sales of actuators have also posted growth for the first time since the product recall in 2014. Operating income excluding one-off items is still lower than last year. The quarter continued to be

There are no items matching the current filter
There are no more items matching the current filter
Back to top